UVI3502
UVI3502 is a cannabinoid receptor 1 (CB1) antagonist with an IC50 value of 4641 nM for CB1 and approximately 16200 nM for CB2. UVI3502 blocks Gi/o protein coupling induced by the agonist CP55,940. UVI3502 is promising for research of endocannabinoid system-related diseases in the central nervous system (such as cognitive impairment and neurodegenerative diseases) [1].
Product Specifications
UNSPSC
12352005
Target
Cannabinoid Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Smiles
COC1=CC2=C(N(C(OCC)=O)C(C(C=C(C)C=C3)=C3NC/4=O)=C2C4=C\C(OCC)=O)C=C1
Molecular Formula
C25H24N2O6
Molecular Weight
448.47
References & Citations
[1]Bengoetxea de Tena I, et al. Synthesis and Pharmacological Characterization of a Novel Cannabinoid Receptor 1 Antagonist. ACS Omega. 2025 Jun 2;10 (22) :22747-22759.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1; CB2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
